Paper39109293
The Groebke-Blackburn-Bienaymé reaction in its maturity: innovation and improvements since its 21st birthday (2019-2023).
Martini C and 2 others. Beilstein J Org Chem, 2024. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. The Groebke-Blackburn-Bienaymé reaction in its maturity: innovation and improvements since its 21st birthday (2019-2023). Papers, record 39109293. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39109293
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The Groebke-Blackburn-Bienaymé reaction in its maturity: innovation and improvements since its 21st birthday (2019-2023).
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References69
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24448805 | Enhanced enzyme kinetic stability by increasing rigidity within the active site. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24448805 | PubMed |
| 2 | 30622248 | The transcription factor STAT5 catalyzes Mannich ligation reactions yielding inhibitors of leukemic cell proliferation. | Nat Commun | 2019 | https://conductscience.org/library/papers/30622248 | PubMed |
| 3 | 33071311 | Multicomponent Reactions: "Kinderleicht". | J Chem Educ | 2020 | https://conductscience.org/library/papers/33071311 | PubMed |
| 4 | 37310879 | Groebke-Blackburn-Bienaymé Reaction for DNA-Encoded Library Technology. | Org Lett | 2023 | https://conductscience.org/library/papers/37310879 | PubMed |
| 5 | 33906641 | Small molecule inhibitors against PD-1/PD-L1 immune checkpoints and current methodologies for their development: a review. | Cancer Cell Int | 2021 | https://conductscience.org/library/papers/33906641 | PubMed |
| 6 | 35514898 | Two decades of recent advances of Ugi reactions: synthetic and pharmaceutical applications. | RSC Adv | 2020 | https://conductscience.org/library/papers/35514898 | PubMed |
| 7 | 25727702 | Recent advances in cancer therapeutics. | Prog Med Chem | 2015 | https://conductscience.org/library/papers/25727702 | PubMed |
| 8 | 30065985 | Planar chiral [2.2]paracyclophanes: from synthetic curiosity to applications in asymmetric synthesis and materials. | Chem Soc Rev | 2018 | https://conductscience.org/library/papers/30065985 | PubMed |
| 9 | 29974986 | Multiple Multicomponent Reactions: Unexplored Substrates, Selective Processes, and Versatile Chemotypes in Biomedicine. | Chemistry | 2018 | https://conductscience.org/library/papers/29974986 | PubMed |
| 10 | 37431831 | N-Edited Guanine Isosteres. | J Org Chem | 2023 | https://conductscience.org/library/papers/37431831 | PubMed |
| 11 | 36824604 | 'Chemistry at the speed of sound': automated 1536-well nanoscale synthesis of 16 scaffolds in parallel. | Green Chem | 2023 | https://conductscience.org/library/papers/36824604 | PubMed |
| 12 | 31464126 | Isocyanide Multicomponent Reactions on Solid-Phase-Coupled DNA Oligonucleotides for Encoded Library Synthesis. | Org Lett | 2019 | https://conductscience.org/library/papers/31464126 | PubMed |
| 13 | 36646043 | Construction of Covalent Organic Frameworks via Multicomponent Reactions. | J Am Chem Soc | 2023 | https://conductscience.org/library/papers/36646043 | PubMed |
| 14 | 35830622 | Synthesis of Tunable Fluorescent Imidazole-Fused Heterocycle Dimers. | Org Lett | 2022 | https://conductscience.org/library/papers/35830622 | PubMed |
| 15 | 38371912 | The full spectrum tuning of fluorescent molecules via a one-pot multicomponent reaction. | Tetrahedron Lett | 2023 | https://conductscience.org/library/papers/38371912 | PubMed |
| 16 | 28722178 | CDK9: A key player in cancer and other diseases. | J Cell Biochem | 2018 | https://conductscience.org/library/papers/28722178 | PubMed |
| 17 | 36914696 | Nickel substituted polyoxometalates in layered double hydroxides as metal-based nanomaterial of POM-LDH for green catalysis effects. | Sci Rep | 2023 | https://conductscience.org/library/papers/36914696 | PubMed |
| 18 | 27983738 | To each his own: isonitriles for all flavors. Functionalized isocyanides as valuable tools in organic synthesis. | Chem Soc Rev | 2017 | https://conductscience.org/library/papers/27983738 | PubMed |
| 19 | 36051621 | Phosphonic acid-containing inhibitors of tyrosyl-DNA phosphodiesterase 1. | Front Chem | 2022 | https://conductscience.org/library/papers/36051621 | PubMed |
| 20 | 37929127 | Imidazo[1,2-a]pyrimidine as a New Antileishmanial Pharmacophore against Leishmania amazonensis Promastigotes and Amastigotes. | ACS Omega | 2023 | https://conductscience.org/library/papers/37929127 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42835876 | Expanded use of benzamidines in the Groebke-Blackburn-Bienaymé synthesis of imidazoles and their biological evaluation. | Beilstein J Org Chem | 2026 | https://conductscience.org/library/papers/42835876 | PubMed |
| 42428833 | Synthesis, Characterization, and Application of a Novel Polystyrene-Supported Brønsted-Acidic Ionic Liquid as an Efficient and Reusable Catalyst in Microwave-Assisted Groebke-Blackburn-Bienaymé Multicomponent Reaction. | ACS Omega | 2026 | https://conductscience.org/library/papers/42428833 | PubMed |
| 42205732 | Preparation of 3-(alkylamino)imidazo[1,2-a]pyridine-2-carbaldehydes via Kornblum oxidation and unexpected ring-opening reactions of the corresponding alcohols under oxidative conditions. | Beilstein J Org Chem | 2026 | https://conductscience.org/library/papers/42205732 | PubMed |
| 41908398 | Solvent Effects on the Photophysical Properties of Unexplored Imidazo[1,2‑a]pyridine Derivatives. | ACS Omega | 2026 | https://conductscience.org/library/papers/41908398 | PubMed |
| 40589428 | A multicomponent reaction-initiated synthesis of imidazopyridine-fused isoquinolinones. | Beilstein J Org Chem | 2025 | https://conductscience.org/library/papers/40589428 | PubMed |
| 40317604 | The Evolution of Fluorescein into A Potential Theranostic Tool. | Chemistry | 2025 | https://conductscience.org/library/papers/40317604 | PubMed |
| 39519692 | Identification of a New Promising BAG3 Modulator Featuring the Imidazopyridine Scaffold. | Molecules | 2024 | https://conductscience.org/library/papers/39519692 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39109293
GET https://conductscience.org/api/papers/v1/39109293/references?page=2